Identification of a putative nuclear localization sequence within ANG II AT1A receptor associated with nuclear activation

American Journal of Physiology - Cell Physiology

Volumn 292, Issue 4, 2007, Pages

  Morinelli, Thomas A ^a   Raymond, John R ^a   Baldys, Aleksander ^a   Yang, Qing ^a   Lee, Mi Hye ^a   Luttrell, Louis ^a   Ullian, Michael E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cyclooxygenase 2 transcription; G protein coupled receptors; Laser scanning confocal microscopy

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II; CALCIUM; CYCLOOXYGENASE 2; EARLY GROWTH RESPONSE FACTOR 1; GREEN FLUORESCENT PROTEIN; LAMIN B; LYSINE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL COMMUNICATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION; WILD TYPE;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL LINE; CELL NUCLEUS; CYCLOOXYGENASE 2; EARLY GROWTH RESPONSE PROTEIN 1; GREEN FLUORESCENT PROTEINS; HUMANS; MEMBRANE PROTEINS; MUTATION; NUCLEAR LOCALIZATION SIGNALS; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

EID: 34247346825     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00337.2006     Document Type: Article

References (45)

1. Barak LS, Tiberi M, Freedman NJ, Kwatra MM, Lefkowitz RJ, Caron MG. A highly conserved tryosine residue in G protein-coupled receptors is required for agonist-mediated β2-adrenergic receptor sequestration. J Biol Chem 269: 2790-2795, 1994.
2. Bhat G, Thekkumkara T, Thomas W, Conrad K, Baker K. Angiotensin II stimulates sis-inducing factor-like DNA binding activity. Evidence that the AT1A receptor activates transcription factor-Stat91 and/or a related protein. J Biol Chem 269: 31443-31449, 1994.
3. Booz GW, Conrad KM, Hess AL, Singer HA, Baker KM. Angiotensin-II-binding sites on hepatocyte nuclei. Endocrinology 130: 3641-3649, 1992.
4. Camargo de Andrade MC, Di Marco GS, de Paulo Castro Teixeira V, Mortara RA, Sabatini RA, Pesquero JB, Boim MA, Carmona AK, Schor N, Casarini DE. Expression and localization of N-domain ANG I-converting enzymes in mesangial cells in culture from spontaneously hypertensive rats. Am J Physiol Renal Physiol 290: F364-F375, 2006.
5. Chen R, Mukhin YV, Garnovskaya MN, Thielin TE, Iijima Y, Huang C, Raymond JR, Ullian ME, Paul RV. A functional angiotensin II receptor-GFP fusion protein: evidence form agonist-dependent nuclear translocation. Am J Physiol Renal Physiol 279: F440-F448, 2000.
6. Derbyshire ZE, Halfter UM, Heimark RL, Sy TH, Vaillancourt RR. Angiotensin II stimulated transcription of cyclooxygenase II is regulated by a novel kinase cascade involving Pyk2, MEKK4 and annexin II. Mol Cell Biochem 271: 77-90, 2005.
7. Dingwall C, Laskey RA. Nuclear targeting sequences-a consensus? Trends Biochem Sci 16: 478-481, 1992.
8. Duff JL, Marrero MB, Paxton WG, Schieffer B, Bernstein KE, Berk BC. Angiotensin II signal transduction and the mitogen-activated protein kinase pathway. Cardiovasc Res 30: 511-517, 1995.
9. Eggena P, Zhu JH, Clegg K, Barrett JD. Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA. Hypertension 22: 496-501, 1993.
10. Eggena P, Zhu JH, Sereevinyayut S, Giordani M, Clegg K, Andersen PC, Hyun P, Barrett JD. Hepatic angiotensin II nuclear receptors and transcription of growth-related factors. J Hypertens 14: 961-968, 1996.
11. 2+ increases in A7r5 vascular smooth muscle cells. Eur J Pharmacol 420: 9-18, 2001.
12. Filipeanu CM, Henning RH, de Zeeuw D, Nelemans A. Intracellular angiotensin II and cell growth of vascular smooth muscle cells. Br J Pharmacol 132: 1590-1596, 2001.
13. Gaborik Z, Jagadeesh G, Zhang M, Spat A, Catt KJ, Hunyady L. The role of a conserved region of the second intracellular loop in AT1 angiotensin receptor activation and signaling. Endocrinology 144: 2220-2228, 2003.
14. Gaborik Z, Szaszak M, Szidonya L, Balla B, Paku S, Catt KJ, Clark AJL, Hunyady L. β-Arrestin- and dynamin-dependent endocytosis of the AT1 angiotensin receptor. Mol Pharmacol 59: 239-247, 2001.
15. Gashler A, Sukhatme VP. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol 50: 191-224, 1995.
16. Gasparo MD, Catt KJ, Inagami T, Wright JW, Unger T. International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472, 2000.
17. 1A cells. J Biol Chem 276: 39394-39403, 2001.
18. Haendeler J, Berk BC. Angiotensin II mediated signal transduction. Important role of tyrosine kinases. Regul Pept 95: 1-7, 2000.
19. Haller H, Lindschau C, Quass P, Luft FC. Intracellular actions of angiotensin II in vascular smooth muscle cells. J Am Soc Nephrol 10: S75-S83, 1999.
20. Hodel MR, Corbett AH, Hodel AE. Dissection of a nuclear localization signal. J Biol Chem 276: 1317-1325, 2001.
21. Hu ZW, Kerb R, Shi XY, Wei-Lavery T, Hoffman BB. Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells. J Pharmacol Exp Ther 303: 563-573, 2002.
22. 1 angiotensin receptor. J Biol Chem 269: 31378-31382, 1994.
23. Hunyady L, Bor M, Baukal AJ, Balla T, Catt KJ. A conserved NPLFY sequence contributes to agonist binding and signal transduction but is not an internalization signal for the type 1 angiotensin II receptor. J Biol Chem 270: 16602-16609, 1995.
24. Kang J, Shi Y, Xiang B, Qu B, Su W, Zhu M, Zhang M, Bao G, Wang F, Zhang X. A nuclear function of β-arrestin 1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell 123: 833-847, 2005.
25. 2 receptors. J Biol Chem 279: 7901-7908, 2004.
26. Ling S, Dai A, Ma YH, Wilson E, Chatterjee K, Ives HE, Sudhir K. Matrix-dependent gene expression of egr-1 and PDGF A regulate angiotensin II-induced proliferation in human vascular smooth muscle cells. Hypertension 34: 1141-1146, 1999.
27. Lu D, Yang H, Shaw G, Raizada MK. Angiotensin II-induced nuclear targeting of the angiotensin type 1 (AT1) receptor in brain neurons. Endocrinology 139: 365-375, 1998.
28. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, Lefkowitz RJ. Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds. Proc Natl Acad Sci USA 98: 2449-2454, 2001.
29. Makkerh JP, Dingwall C, Laskey RA. Comparative mutagenesis of nuclear localization signals reveals the importance of neutral and acidic amino acids. Curr Biol 6: 1025-1027, 1996.
30. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE. Direct stimulation of Jak/STAT pathway by the angiotensin II receptor. Nature 375: 247-250, 1995.
31. Ohnaka K, Numaguchi K, Yamakawa T, Inagami T. Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells. Hypertension 35: 68-75, 2000.
32. Pokholok DK, Zeitlinger J, Hannett NM, Reynolds DB, Young RA. Activated signal transduction kinases frequently occupy target genes. Science 313: 533-536, 2006.
33. Re R, Parab M. Effect of angiotensin II on RNA synthesis by isolated nuclei. Life Sci 34: 647-651, 1984.
34. Re RN, LaBiche RA, Bryan SE. Nuclear hormone mediated changes in chromatin solubility. Biochem Biophys Res Commun 110: 61-68, 1983.
35. Robbins J, Dilworth SM, Laskey RA, Dingwall C. Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell 64: 615-623, 1991.
36. Seta K, Nanamori M, Modrall JG, Neubig RR, Sadoshima J. AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs. J Biol Chem 277: 9268-9277, 2002.
37. Shamim A, Pelzer T, Grohe C, Neyses L. Induction of Egr-1 mRNA and protein by endothelin 1, angiotensin II and norepinephrine in neonatal cardiac myocytes. Mol Cell Biochem 195: 11-17, 1999.
38. Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56: 387-437, 2004.
39. Simone C, Forcales SV, Hill DA, Imbalzano AN, Latella L, Puri PL. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat Genet 36: 738-743, 2004.
40. Smith RD, Hunyady L, Olivares-Reyes JA, Mihalik B, Jayadev S, Catt KJ. Agonist-induced phosphorylation of the angiotensin AT1a receptor is localized to a serine/threonine-rich region of its cytoplasmic tail. Mol Pharmacol 54: 935-941, 1998.
41. Tang SS, Rogg H, Schumacher R, Dzau VJ. Characterization of nuclear angiotensin-II-binding sites in rat liver and comparison with plasma membrane receptors. Endocrinology 131: 374-380, 1992.
42. Thomas WG, Baker KM, Motel TJ, Thekkumkara TJ. Angiotensin II receptor endocytosis involves two distinct regions of the cytoplasmic tail: a role for residues on the hydrophobic face of a putative amphipathic helix. J Biol Chem 270: 22153-22159, 1995.
43. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52: 639-672, 2000.
44. Turner NA, Ball SG, Balmforth AJ. The mechanism of angiotensin II-induced extracellular signal-regulated kinase-1/2 activation is independent of angiotensin AT1A receptor internalisation. Cell Signal 269: 269-277, 2001.
45. Zhang J, Ferguson SSG, Barak LS, Menard L, Caron MG. Dynamin and β-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization. J Biol Chem 271: 18302-18305, 1996.